A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Condition(s):Sickle Cell DiseaseLast Updated:April 5, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:April 5, 2023Recruiting
Condition(s):Retinal Vein OcclusionLast Updated:December 21, 2018Completed
Condition(s):Neurodegenerative DisordersLast Updated:July 2, 2017Unknown status
Condition(s):DyslipidemiasLast Updated:January 29, 2013Terminated
Condition(s):Parkinson DiseaseLast Updated:October 4, 2023Recruiting
Condition(s):Delirium Confusional StateLast Updated:January 26, 2021Unknown status
Condition(s):HealthyLast Updated:March 5, 2024Terminated
Condition(s):Allogeneic Hematopoietic Cell TransplantationLast Updated:October 11, 2023Recruiting
Condition(s):Type 2 Diabetes Mellitus; ObesityLast Updated:April 7, 2023Suspended
Condition(s):Skin DarkenLast Updated:November 24, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.